+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Cardiovascular Training Equipment Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Treadmills, Elliptical Trainers and Cross-Trainers, Stationary Bicycles and Dynamic Indoor Cycles, Rowing Machines, Stair Steppers and Climbing Machines), By Connectivity Type (Connected , Non-Connected ), By End-User (Commercial Outlets , Residential Consumers , Institutional Buyers , Hospitality and Medical Settings ), By Distribution Channel (Specialty Sports and Fitness Shops, Online Stores and E-Commerce Platforms, Direct-to-Consumer , Mass Merchandisers and Department Stores) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Training Equipment Market size is forecast to increase from $10.76 Billion in 2026 to $16.64 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006227
Pages: 220 Pages

Cardiovascular Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Anti-Hypertensives, Anti-Hyperlipidermics , Anti-Coagulants and Anti-Platelet Drugs, Anti-Arrhythmics, Anti-Fibrinolytics and Thrombolytics), By Disease Indication (Hypertension, Coronary Artery Disease , Heart Failure, Arrhythmia, Hyperlipidemia , Stroke and Peripheral Artery Disease ), By Drug Classification (Branded Therapeutics, Generic Therapeutics), By Route of Administration (Oral Administration, Parenteral ), By Mode of Purchase (Prescription-Based Drugs , Over-the-Counter Drugs ), By Distribution Channel (Hospital Pharmacies, Retail and Community Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Therapeutics Market size is forecast to increase from $147.04 Billion in 2026 to $204.35 Billion in 2034 at a CAGR of 4.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006226
Pages: 226 Pages

Cardiovascular Repair and Reconstruction Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Heart Valve Repair Devices , Vascular Grafts , Cardiovascular Patches , Annuloplasty Rings and Fixation Systems), By Clinical Application (Heart Valve Repair & Replacement, Congenital Heart Defect Repair, Vascular Reconstruction, Cardiac Tissue and Myocardial Reconstruction), By Surgical Technology (Traditional Open Surgical Technology, Minimally Invasive , Tissue-Engineered and Bioresorbable Technology), By End-User (Hospitals and Hybrid Operating Rooms, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers , Specialty Cardiovascular Clinics) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Repair and Reconstruction Devices Market size is forecast to increase from $4.55 Billion in 2026 to $7.14 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006225
Pages: 230 Pages

Cardiovascular Needle Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Taper Point Needles, Cutting Needles, Tapercut Needles, Reverse Cutting Needles), By Material (Stainless Steel, Carbon Steel, Others), By Application (Cardiovascular Surgery, Vascular Procedures, Coronary Bypass Grafting, Heart Valve Replacement), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Needle Market size is forecast to increase from $103.93 Billion in 2026 to $186.74 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006224
Pages: 213 Pages

Cardiovascular Medical Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product (Cardiac Rhythm Management Devices, Interventional Cardiology Devices, Cardiac Surgery Devices, Prosthetic Heart Valves, Cardiovascular Monitoring and Diagnostic Devices), By Indication (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Valvular Heart Disease, Congenital Heart Defects), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Medical Devices Market size is forecast to increase from $64.09 Billion in 2026 to $120.39 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006223
Pages: 224 Pages

Cardiovascular Information System Market Size, Share and Growth Outlook, 2026: Analysis By Product (Software, Hardware, Services), By Deployment Mode (Cloud-based, On-premises, Web-based), By Component (Cardiology PACS, CVIS Core, ECG Management Systems, Electrophysiology Systems), By End-User (Hospitals, Cardiology Clinics, Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Information System Market size is forecast to increase from $1.51 Billion in 2026 to $2.77 Billion in 2034 at a CAGR of 7.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006222
Pages: 227 Pages

Cardiovascular Implants Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Coronary Stents , Heart Valves , Cardiac Rhythm Management , Vascular Grafts, Occluders & Ligation Devices), By Material (Metallic Alloys , Polymers, Biological Materials ), By Application (Arrhythmia Management, Myocardial Ischemia, Heart Valve Replacement, Acute Myocardial Infarction), By End-User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Implants Market size is forecast to increase from $41.9 Billion in 2026 to $81.67 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006221
Pages: 225 Pages

Cardiovascular Health Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Type (Natural Supplements, Synthetic Supplements), By Ingredient (Omega-3 Fatty Acids , Vitamins & Minerals , Herbs & Botanicals , Amino Acids , Plant Sterols & Stanols), By Dosage Form (Tablets & Capsules, Softgels, Powders, Liquids, Gummies), By Distribution Channel (Online Retail, Pharmacy & Drugstores, Supermarkets & Hypermarkets, Specialty Health Stores) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Health Supplements Market size is forecast to increase from $12.38 Billion in 2026 to $24.13 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006220
Pages: 228 Pages

Cardiovascular Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Anticoagulants, Antihypertensive Drugs , Antihyperlipidemic Drugs , Antiplatelet Drugs, Anti-Arrhythmic Agents, Vasodilators), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease , Heart Failure, Cardiac Arrhythmia), By Route of Administration (Oral, Parenteral , Transdermal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Drugs Market size is forecast to increase from $168.85 Billion in 2026 to $232.87 Billion in 2034 at a CAGR of 4.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006219
Pages: 228 Pages

Cardiovascular Digital Solutions Market Size, Share and Growth Outlook, 2026: Analysis By Core Component (Hardware , Software Platforms ), By Service (Unobtrusive Testing and Diagnostic Monitoring, Cardiovascular Disease , Digital Cardiac Rehabilitation Programs), By Deployment Model (Cloud-Based Platforms, On-Premise Configurations), By Target End-User (Hospitals and Clinical Networks, Ambulatory Care & Telecardiology Centers, Diagnostic Laboratories, Individual Consumers and Patients) Companies, and Country Forecast, 2021 to 2034

Global Cardiovascular Digital Solutions Market size is forecast to increase from $115.94 Billion in 2026 to $172.61 Billion in 2034 at a CAGR of 5.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006218
Pages: 215 Pages